Free Republic

Now that Pat Gelsinger is no longer occupying the corner office at embattled chipmaker Intel (INTC), he can acknowledge one thing about the semiconductor industry.Nvidia (NVDA) has a wide, wide lead over its rivals on the tech front..."They have built meaningful moats around their franchise," he added.Gelsinger led aggressive efforts to turn around Intel for more than three years. He slashed thousands of jobs, improved costs, secured CHIPS Act funding, built chip foundries, and promised fast AI chips that could compete with Nvidia and AMD (AMD).He was fired in early December amid missed financial targets, lack of progress on the...

AMD has announced that its key processor chips will soon be produced at TSMC’s new facility in Arizona, marking the first time AMD’s products will be manufactured in the United States. The news comes on the heels of AI giant Nvidia announcing it will produce AI chips and supercomputers in Arizona and Texas. Reuters reports that AMD CEO Lisa Su revealed that the company’s fifth-generation EPYC CPUs for data centers will be manufactured at TSMC’s Arizona plant. This decision comes amidst growing concerns over the U.S.-China trade tensions and the potential impact of tariffs on the semiconductor industry. The Trump...

Chip designers Nvidia and Broadcom are running manufacturing tests with Intel, two sources familiar with the matter told Reuters... indicate the companies are moving closer to determining whether they will commit hundreds of millions of dollars' worth of manufacturing contracts to Intel...Advanced Micro Devices is also evaluating whether Intel's 18A manufacturing process is suitable for its needs but it was unclear if it had sent test chips through the factory...The success of Intel's contract manufacturing business, or foundry, was the centerpiece of former CEO Pat Gelsinger's plan to revive the once iconic American technology company. But the board fired Gelsinger...

Rumors are swirling about a possible takeover of Intel. Nothing has been inked, but Broadcom and Taiwan Semiconductor Manufacturing Company (TSMC) both are in the early stages of proposing potential deals, according to The Wall Street Journal. Broadcom could potentially seek a deal for Intel’s chip design assets, while TSMC eyes its manufacturing capabilities.Intel interim executive chairman allegedly met with buyers, government Broadcom and TSMC are not officially working together, and any plans either company has for deals with Intel are in preliminary stages, The Wall Street Journal said. However, Intel’s Interim Executive Chairman Frank Yeary has allegedly met with...

Broadcom and Taiwan Semiconductor Manufacturing Co. are reportedly weighing plans to bid for Intel that would result in the storied chipmaker breaking up.According to The Wall Street Journal in a report Saturday, Broadcom has been looking into Intel’s chip-design and marketing business and and has “informally discussed” a bid with its advisers if it finds a partner for Intel’s chip-making operations.The report said TSMC has examined taking over some or all of Intel’s chip plants, meanwhile, as part of an investor consortium or another structure.

A study has linked low levels of oxygen in the blood overnight—a common sign of obstructive sleep apnea—with wet age-related macular degeneration. The findings suggest obstructive sleep apnea (OSA) could be a modifiable risk factor associated with the "wet" form of late-stage age-related macular degeneration (AMD). The team conducted a sleep study involving 225 participants aged over 50 with different stages of AMD and measured their oxygen levels over three nights with a home-based finger oximeter. Their level of OSA was calculated based on the oxygen levels in their blood overnight. The results showed that moderate-to-severe OSA, which results in...

President-elect Donald Trump made raising tariffs on imported goods a tenet of his reelection campaign. And while that could raise prices on everything from jeans to children’s toys for everyday Americans, Trump has also floated the idea of another tariff that could impact Wall Street’s current favorite trade: AI. During an appearance on Joe Rogan’s podcast ahead of the election, Trump lambasted the idea of the CHIPS Act, a bipartisan piece of legislation Biden signed in 2022 designed to bring semiconductor manufacturing back to the US. He called it “so bad.” Instead of using legislation and billions in subsidies to...

Key Points AMD said on Wednesday that it will lay off 4% of its global staff. AMD had 26,000 employees at the end of last year, according to a U.S. Securities and Exchange Commission filing. AMD is the second-biggest producer of graphics processing units, or GPUs, behind Nvidia. ============================================================= AMD said on Wednesday that it will lay off 4% of its global staff as the longtime computer chipmaker seeks to gain a stronger foothold in the growing artificial intelligence chip space dominated by Nvidia. ″As a part of aligning our resources with our largest growth opportunities, we are taking a...

A study from Tufts University found that daily consumption of pistachios can enhance eye health by increasing macular pigment optical density (MPOD), which helps protect against blue light and age-related eye damage. This benefit is attributed to pistachios’ unique content of lutein, a plant pigment essential for eye health and potentially useful in preventing age-related macular degeneration (AMD). Daily pistachios boost eye health by raising lutein, protecting against age-related damage, and supporting brain function. A recent study by researchers at Tufts University’s Friedman School of Nutrition Science and Policy suggests that eating pistachios daily may greatly benefit eye health. This...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a study says. The therapy, called photobiomodulation or "red light" therapy, can reduce the risk of vision loss and slow progression of the "dry" form of macular degeneration, researchers reported. About eight out of 10 people with macular degeneration have the "dry" form of the disease. They slowly lose central vision as the macula—a small but important area in the center of the retina—becomes thinner and accumulates tiny clumps of protein called drusen. There are effective drugs available for people with "wet" AMD, in...

Researchers have identified a protein that may prevent age-related macular degeneration (AMD), according to a new study published in the Developmental Cell on Oct. 2.AMD is the leading cause of vision loss among older adults, affecting nearly 20 million Americans. As the population ages, this number is expected to rise significantly. Currently, there are no treatments that can stop AMD’s progression.MR.PRAWET THADTHIAM/Shutterstock“I think we identified something that can target early-stage disease. ... That’s a big deal,” the study’s lead author Ruchira Singh, an associate professor of ophthalmology at the University of Rochester in New York, told The Epoch Times.The study...

Nvidia on Sunday unveiled its next generation of artificial intelligence chips to succeed the previous model, which was announced just months earlier in March.Nvidia CEO Jensen Huang announced the new AI chip architecture, dubbed "Rubin," ahead of the COMPUTEX tech conference in Taipei.Rubin comes months after the March announcement of the upcoming "Blackwell" model, which is still in production and expected to ship to customers later in 2024.Huang's announcement of Rubin appears to quicken the company's already-accelerated pace of AI chip advancement.Nvidia has pledged to release new AI chip models on a "one-year rhythm," as Huang put it on Sunday....

Advanced Micro Devices(NASDAQ: AMD) recorded another day of strong gains in Friday's daily trading. The semiconductor company's share price closed out the session up 5.3%, according to data from S&P Global Market Intelligence. While there wasn't any business-specific news for AMD, its share price surged in conjunction with the latest bullish indicators for AI demand and growth opportunities. Dell published its fourth-quarter report after the market closed Thursday, and its results have spurred another round of bullish momentum for artificial intelligence (AI) stocks. Dell's Q4 results are the latest bullish catalyst for AI stocks If Wall Street was looking for...

As levels of nighttime artificial outdoor light rise, so do the odds for a leading cause of vision loss, age-related macular degeneration (AMD). Researchers found that people living in areas of that country with the highest levels of streetlights and other artificial light had more than double the odds for AMD, compared to those living in areas with the lowest levels. That risk remained even after they accounted for confounding factors such as sleep issues and depression, said a team led by Dr. Ahnul Ha. City dwellers may be at particular danger for macular degeneration, since the link between the...

Research led by Nicolas Bazan, MD, Ph.D. suggests that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential. The discovery may also open new therapeutic avenues for AMD. The study shows that AMD decreases peripheral retinal docosahexaenoic acid (DHA) 22:6 in rod photoreceptor cells, limiting the elongation of fatty acids to form very-long-chain polyunsaturated fatty acids (VLC-PUFAs). VLC-PUFAs are precursors of elovanoids, bioactive chemical messengers made from omega-3 very- long-chain polyunsaturated fatty acids. Elovanoids, discovered by the Bazan lab, have been shown to restore the structure and...

Researchers have identified the role that two key genes associated with age-related macular degeneration (AMD) play in the disease. The team have for the first time found that the genes TMEM97 and POLDIP2 play a role in regulating oxidative stress—a part of aging in the macula. The findings provide a deeper understanding of the underlying causes of AMD and help prioritize new gene targets for treatments. AMD affects the macula—the central part of the retina at the back of the eye—causing cells to gradually break down, often leading to blurred central vision. Previous studies have identified many genes that are...

Intel CEO Pat Gelsinger has defended the company's plan to become a chipmaker for hire after the company's profits plunged 134 percent year over year and it recorded a $2.8 billion loss during the first quarter of 2023. Intel has traditionally built fabrication plants to manufacture its own chips, but has seldom built silicon for third parties. Gelsinger reversed that policy, deciding that Intel must develop a substantial foundry business. "While everyone understands that we are establishing an internal foundry model, I'm not sure we have fully explained the importance and impact of this change," he said, insisting that hiring...

Dietary nitrate intake is associated with a lower risk for progression of age-related macular degeneration (AMD), according to a study. Geoffrey K. Broadhead, M.D., Ph.D., from the National Eye Institute at the National Institutes of Health in Bethesda, Maryland, and colleagues examined the association between dietary nitrate intake and AMD progression using data from the prospective Age-Related Eye Disease Study (AREDS) and AREDS2 randomized clinical trial cohorts and extended follow-up studies. Data were included for 7,788 participants in the combined AREDS/AREDS2 cohort, with 13,511 eligible eyes. The researchers found that in the combined AREDS/AREDS2 cohort, dietary nitrate intake was associated...

A pilot, "look-back" study of information about 106 patients with "wet" age-related macular degeneration (AMD) has revealed that nearly half of patients treated with aflibercept could safely stop eye injection therapy after one year without further vision loss. Only 17% of patients taking another commonly used wet AMD therapy, bevacizumab, were able to safely wean from the drug at a year. The findings build on evidence from a previous study that found potentially a third of patients with wet AMD could safely pause therapy after one year of monitoring by a physician. "Our results suggest that many patients with macular...

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness, are also highly likely to have either underlying heart damage from heart failure and heart attacks, or advanced heart valve disease, or carotid artery disease associated with certain types of strokes, according to a study. This research, is the first to identify which types of high-risk cardiovascular and carotid artery disease are linked to the eye disorder. "We have been able to connect these specific high-risk cardiovascular diseases to a specific form of AMD, the one with subretinal drusenoid deposits (SDDs)," explains R. Theodore Smith,...